|
KMID : 0939920130450010074
|
|
대한암학회지
2013 Volume.45 No. 1 p.74 ~ p.77
|
|
|
Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer
|
|
Kim Kyeong-Hyun
Song Seo-Young
Lim Kyu-Hyoung
Han Seon-Sook
Kim Se-Hyun
Cho Jun-Hwi
Park Chan-Woo
Lee Seoung-Koo
Lee Hui-Young
|
|
|
Abstract
|
|
|
|
Pemetrexed is approved as a first-line treatment for advanced non-squamous non-small cell lung cancer (NSCLC) with cisplatin and as a single agent for second-line treatment or for patients who show no disease progression after four cycles of platinum-based doublet induction chemotherapy as maintenance therapy. Pemetrexed has a modest toxicity profile and has not traditionally been regarded as a cause of interstitial pneumonitis. Here, we report on a rare case of pemetrexed-induced pneumonitis in a patient with NSCLC.
|
|
|
KEYWORD
|
|
|
Interstitial lung diseases, Pemetrexed, Non-small-cell lung carcinoma, Adenocarcinoma, Drug therapy
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|